Recombinant Proteins Market - Global Outlook and Forecast 2022-2028

January 2022 | 106 pages | ID: RDD504EE470BEN
Market Monitor Global

Abstracts

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.

This report contains market size and forecasts of Recombinant Proteins in Global, including the following market information:

Global Recombinant Proteins Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Recombinant Proteins market was valued at 740.2 million in 2021 and is projected to reach US$ 1248.3 million by 2028, at a CAGR of 7.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hormones Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Proteins include Abcam PLC, R&D Systems, Miltenyi Biotec, Thermo Fisher Scientific, Sigma Aldrich Company, GE Healthcare, Lonza, Merck KGaA and ProSpec Tany TechnoGene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Proteins companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Proteins Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Proteins Market Segment Percentages, by Type, 2021 (%)

• Hormones
• Growth Factors
• Cytokines
• Plasma Protein Factor
• Recombinant Metabolic Enzymes
• Immune Checkpoint Regulators
• Others

Global Recombinant Proteins Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Proteins Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Academic and Research Institutes
• Contract Research Organizations

Global Recombinant Proteins Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Recombinant Proteins Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Proteins revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Recombinant Proteins revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abcam PLC
• R&D Systems
• Miltenyi Biotec
• Thermo Fisher Scientific
• Sigma Aldrich Company
• GE Healthcare
• Lonza
• Merck KGaA
• ProSpec Tany TechnoGene
• Eurogentec (Kaneka Corporation)
• PeproTech
• BPS Bioscience
• Reprocell
• GenScript Biotech Corporation
• Abnova Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Proteins Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Proteins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT PROTEINS OVERALL MARKET SIZE

2.1 Global Recombinant Proteins Market Size: 2021 VS 2028
2.2 Global Recombinant Proteins Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Recombinant Proteins Players in Global Market
3.2 Top Global Recombinant Proteins Companies Ranked by Revenue
3.3 Global Recombinant Proteins Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Proteins Companies in Global Market, by Revenue in 2021
3.5 Global Companies Recombinant Proteins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Proteins Players in Global Market
  3.6.1 List of Global Tier 1 Recombinant Proteins Companies
  3.6.2 List of Global Tier 2 and Tier 3 Recombinant Proteins Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Recombinant Proteins Market Size Markets, 2021 & 2028
  4.1.2 Hormones
  4.1.3 Growth Factors
  4.1.4 Cytokines
  4.1.5 Plasma Protein Factor
  4.1.6 Recombinant Metabolic Enzymes
  4.1.7 Immune Checkpoint Regulators
  4.1.8 Others
4.2 By Type - Global Recombinant Proteins Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Proteins Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant Proteins Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant Proteins Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Proteins Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Academic and Research Institutes
  5.1.4 Contract Research Organizations
5.2 By Application - Global Recombinant Proteins Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Proteins Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant Proteins Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant Proteins Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Proteins Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Proteins Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Proteins Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant Proteins Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant Proteins Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Recombinant Proteins Revenue, 2017-2028
  6.3.2 US Recombinant Proteins Market Size, 2017-2028
  6.3.3 Canada Recombinant Proteins Market Size, 2017-2028
  6.3.4 Mexico Recombinant Proteins Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Recombinant Proteins Revenue, 2017-2028
  6.4.2 Germany Recombinant Proteins Market Size, 2017-2028
  6.4.3 France Recombinant Proteins Market Size, 2017-2028
  6.4.4 U.K. Recombinant Proteins Market Size, 2017-2028
  6.4.5 Italy Recombinant Proteins Market Size, 2017-2028
  6.4.6 Russia Recombinant Proteins Market Size, 2017-2028
  6.4.7 Nordic Countries Recombinant Proteins Market Size, 2017-2028
  6.4.8 Benelux Recombinant Proteins Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Recombinant Proteins Revenue, 2017-2028
  6.5.2 China Recombinant Proteins Market Size, 2017-2028
  6.5.3 Japan Recombinant Proteins Market Size, 2017-2028
  6.5.4 South Korea Recombinant Proteins Market Size, 2017-2028
  6.5.5 Southeast Asia Recombinant Proteins Market Size, 2017-2028
  6.5.6 India Recombinant Proteins Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Recombinant Proteins Revenue, 2017-2028
  6.6.2 Brazil Recombinant Proteins Market Size, 2017-2028
  6.6.3 Argentina Recombinant Proteins Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Recombinant Proteins Revenue, 2017-2028
  6.7.2 Turkey Recombinant Proteins Market Size, 2017-2028
  6.7.3 Israel Recombinant Proteins Market Size, 2017-2028
  6.7.4 Saudi Arabia Recombinant Proteins Market Size, 2017-2028
  6.7.5 UAE Recombinant Proteins Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abcam PLC
  7.1.1 Abcam PLC Corporate Summary
  7.1.2 Abcam PLC Business Overview
  7.1.3 Abcam PLC Recombinant Proteins Major Product Offerings
  7.1.4 Abcam PLC Recombinant Proteins Revenue in Global Market (2017-2022)
  7.1.5 Abcam PLC Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems Recombinant Proteins Major Product Offerings
  7.2.4 R&D Systems Recombinant Proteins Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Miltenyi Biotec
  7.3.1 Miltenyi Biotec Corporate Summary
  7.3.2 Miltenyi Biotec Business Overview
  7.3.3 Miltenyi Biotec Recombinant Proteins Major Product Offerings
  7.3.4 Miltenyi Biotec Recombinant Proteins Revenue in Global Market (2017-2022)
  7.3.5 Miltenyi Biotec Key News
7.4 Thermo Fisher Scientific
  7.4.1 Thermo Fisher Scientific Corporate Summary
  7.4.2 Thermo Fisher Scientific Business Overview
  7.4.3 Thermo Fisher Scientific Recombinant Proteins Major Product Offerings
  7.4.4 Thermo Fisher Scientific Recombinant Proteins Revenue in Global Market (2017-2022)
  7.4.5 Thermo Fisher Scientific Key News
7.5 Sigma Aldrich Company
  7.5.1 Sigma Aldrich Company Corporate Summary
  7.5.2 Sigma Aldrich Company Business Overview
  7.5.3 Sigma Aldrich Company Recombinant Proteins Major Product Offerings
  7.5.4 Sigma Aldrich Company Recombinant Proteins Revenue in Global Market (2017-2022)
  7.5.5 Sigma Aldrich Company Key News
7.6 GE Healthcare
  7.6.1 GE Healthcare Corporate Summary
  7.6.2 GE Healthcare Business Overview
  7.6.3 GE Healthcare Recombinant Proteins Major Product Offerings
  7.6.4 GE Healthcare Recombinant Proteins Revenue in Global Market (2017-2022)
  7.6.5 GE Healthcare Key News
7.7 Lonza
  7.7.1 Lonza Corporate Summary
  7.7.2 Lonza Business Overview
  7.7.3 Lonza Recombinant Proteins Major Product Offerings
  7.7.4 Lonza Recombinant Proteins Revenue in Global Market (2017-2022)
  7.7.5 Lonza Key News
7.8 Merck KGaA
  7.8.1 Merck KGaA Corporate Summary
  7.8.2 Merck KGaA Business Overview
  7.8.3 Merck KGaA Recombinant Proteins Major Product Offerings
  7.8.4 Merck KGaA Recombinant Proteins Revenue in Global Market (2017-2022)
  7.8.5 Merck KGaA Key News
7.9 ProSpec Tany TechnoGene
  7.9.1 ProSpec Tany TechnoGene Corporate Summary
  7.9.2 ProSpec Tany TechnoGene Business Overview
  7.9.3 ProSpec Tany TechnoGene Recombinant Proteins Major Product Offerings
  7.9.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue in Global Market (2017-2022)
  7.9.5 ProSpec Tany TechnoGene Key News
7.10 Eurogentec (Kaneka Corporation)
  7.10.1 Eurogentec (Kaneka Corporation) Corporate Summary
  7.10.2 Eurogentec (Kaneka Corporation) Business Overview
  7.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Major Product Offerings
  7.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue in Global Market (2017-2022)
  7.10.5 Eurogentec (Kaneka Corporation) Key News
7.11 PeproTech
  7.11.1 PeproTech Corporate Summary
  7.11.2 PeproTech Business Overview
  7.11.3 PeproTech Recombinant Proteins Major Product Offerings
  7.11.4 PeproTech Recombinant Proteins Revenue in Global Market (2017-2022)
  7.11.5 PeproTech Key News
7.12 BPS Bioscience
  7.12.1 BPS Bioscience Corporate Summary
  7.12.2 BPS Bioscience Business Overview
  7.12.3 BPS Bioscience Recombinant Proteins Major Product Offerings
  7.12.4 BPS Bioscience Recombinant Proteins Revenue in Global Market (2017-2022)
  7.12.5 BPS Bioscience Key News
7.13 Reprocell
  7.13.1 Reprocell Corporate Summary
  7.13.2 Reprocell Business Overview
  7.13.3 Reprocell Recombinant Proteins Major Product Offerings
  7.13.4 Reprocell Recombinant Proteins Revenue in Global Market (2017-2022)
  7.13.5 Reprocell Key News
7.14 GenScript Biotech Corporation
  7.14.1 GenScript Biotech Corporation Corporate Summary
  7.14.2 GenScript Biotech Corporation Business Overview
  7.14.3 GenScript Biotech Corporation Recombinant Proteins Major Product Offerings
  7.14.4 GenScript Biotech Corporation Recombinant Proteins Revenue in Global Market (2017-2022)
  7.14.5 GenScript Biotech Corporation Key News
7.15 Abnova Corporation
  7.15.1 Abnova Corporation Corporate Summary
  7.15.2 Abnova Corporation Business Overview
  7.15.3 Abnova Corporation Recombinant Proteins Major Product Offerings
  7.15.4 Abnova Corporation Recombinant Proteins Revenue in Global Market (2017-2022)
  7.15.5 Abnova Corporation Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Recombinant Proteins Market Opportunities & Trends in Global Market
Table 2. Recombinant Proteins Market Drivers in Global Market
Table 3. Recombinant Proteins Market Restraints in Global Market
Table 4. Key Players of Recombinant Proteins in Global Market
Table 5. Top Recombinant Proteins Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Recombinant Proteins Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Recombinant Proteins Revenue Share by Companies, 2017-2022
Table 8. Global Companies Recombinant Proteins Product Type
Table 9. List of Global Tier 1 Recombinant Proteins Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Proteins Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Proteins Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Recombinant Proteins Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Recombinant Proteins Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Recombinant Proteins Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Recombinant Proteins Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Recombinant Proteins Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Recombinant Proteins Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Recombinant Proteins Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Recombinant Proteins Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Recombinant Proteins Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Recombinant Proteins Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Recombinant Proteins Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Recombinant Proteins Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Recombinant Proteins Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Recombinant Proteins Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Recombinant Proteins Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Recombinant Proteins Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Recombinant Proteins Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Recombinant Proteins Revenue, (US$, Mn), 2023-2028
Table 30. Abcam PLC Corporate Summary
Table 31. Abcam PLC Recombinant Proteins Product Offerings
Table 32. Abcam PLC Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems Recombinant Proteins Product Offerings
Table 35. R&D Systems Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 36. Miltenyi Biotec Corporate Summary
Table 37. Miltenyi Biotec Recombinant Proteins Product Offerings
Table 38. Miltenyi Biotec Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Recombinant Proteins Product Offerings
Table 41. Thermo Fisher Scientific Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 42. Sigma Aldrich Company Corporate Summary
Table 43. Sigma Aldrich Company Recombinant Proteins Product Offerings
Table 44. Sigma Aldrich Company Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 45. GE Healthcare Corporate Summary
Table 46. GE Healthcare Recombinant Proteins Product Offerings
Table 47. GE Healthcare Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 48. Lonza Corporate Summary
Table 49. Lonza Recombinant Proteins Product Offerings
Table 50. Lonza Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 51. Merck KGaA Corporate Summary
Table 52. Merck KGaA Recombinant Proteins Product Offerings
Table 53. Merck KGaA Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 54. ProSpec Tany TechnoGene Corporate Summary
Table 55. ProSpec Tany TechnoGene Recombinant Proteins Product Offerings
Table 56. ProSpec Tany TechnoGene Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 57. Eurogentec (Kaneka Corporation) Corporate Summary
Table 58. Eurogentec (Kaneka Corporation) Recombinant Proteins Product Offerings
Table 59. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 60. PeproTech Corporate Summary
Table 61. PeproTech Recombinant Proteins Product Offerings
Table 62. PeproTech Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 63. BPS Bioscience Corporate Summary
Table 64. BPS Bioscience Recombinant Proteins Product Offerings
Table 65. BPS Bioscience Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 66. Reprocell Corporate Summary
Table 67. Reprocell Recombinant Proteins Product Offerings
Table 68. Reprocell Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 69. GenScript Biotech Corporation Corporate Summary
Table 70. GenScript Biotech Corporation Recombinant Proteins Product Offerings
Table 71. GenScript Biotech Corporation Recombinant Proteins Revenue (US$, Mn), (2017-2022)
Table 72. Abnova Corporation Corporate Summary
Table 73. Abnova Corporation Recombinant Proteins Product Offerings
Table 74. Abnova Corporation Recombinant Proteins Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Proteins Segment by Type in 2021
Figure 2. Recombinant Proteins Segment by Application in 2021
Figure 3. Global Recombinant Proteins Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Recombinant Proteins Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Proteins Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Proteins Revenue in 2021
Figure 8. By Type - Global Recombinant Proteins Revenue Market Share, 2017-2028
Figure 9. By Application - Global Recombinant Proteins Revenue Market Share, 2017-2028
Figure 10. By Region - Global Recombinant Proteins Revenue Market Share, 2017-2028
Figure 11. By Country - North America Recombinant Proteins Revenue Market Share, 2017-2028
Figure 12. US Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Recombinant Proteins Revenue Market Share, 2017-2028
Figure 16. Germany Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 17. France Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Recombinant Proteins Revenue Market Share, 2017-2028
Figure 24. China Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 28. India Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Recombinant Proteins Revenue Market Share, 2017-2028
Figure 30. Brazil Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Recombinant Proteins Revenue Market Share, 2017-2028
Figure 33. Turkey Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Recombinant Proteins Revenue, (US$, Mn), 2017-2028
Figure 37. Abcam PLC Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Miltenyi Biotec Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sigma Aldrich Company Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GE Healthcare Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lonza Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck KGaA Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ProSpec Tany TechnoGene Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. PeproTech Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BPS Bioscience Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Reprocell Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GenScript Biotech Corporation Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Abnova Corporation Recombinant Proteins Revenue Year Over Year Growth (US$, Mn) & (2017-2022)